Sfoglia per Autore
Computational approaches to the study of dual-site and peripheral site binding ache inhibitors
2005 Recanatini M.; Cavalli A.; Bottegoni G.
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach
2005 Cavalli A.; Bisi A.; Bertucci C.; Rosini C.; Paluszcak A.; Gobbi S.; Giorgio E.; Rampa A.; Belluti F.; Piazzi L.; Valenti P.; Hartmann R.W.; Recanatini M.
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
2005 Belluti F.; Rampa A.; Piazzi L.; Bisi A.; Gobbi S.; Bartolini M.; Andrisano V.; Cavalli A.; Recanatini M.; Valenti P.
Nonsteroidal Aromatase inhibitors: synthesis and evaluation of new flavone derivatives
2005 S. Gobbi; A. Bisi; F. Belluti; L. Piazzi; A. Rampa; P. Valenti; A. Cavalli; A. Paluszcak; R.W. Hartmann
Heterocyclic inhibitors of AChE acylation and peripheral sites.
2005 Bolognesi M. L.; Andrisano V.; Bartolini M.; Cavalli A.; Minarini A.; Recanatini M.; Rosini M.; Tumiatti V.; Melchiorre C.
QT prolongation through hERG K(+) channel blockade: Current knowledge and strategies for the early prediction during drug development
2005 RECANATINI M.; POLUZZI E.; MASETTI M.; CAVALLI A.; DE PONTI F.
Organocatalytic Asymmetric Conjugate Addition of 1,3-Dicarbonyl Compounds to Maleimides
2006 G. Bartoli; M. Bosco; A. Carlone; A. Cavalli; M. Locatelli; A. Mazzanti; P. Ricci; L. Sambri; P. Melchiorre
Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes.
2006 Favia A. D.; Cavalli A.; Masetti M.; Carotti A.; Recanatini M.
Essential dynamics and metadynamics studies of the conformational changes in the activation loop and PSSARLE of Cdk5
2006 Berteotti A.; Cavalli A.; Branduardi D.; Gervasio F. L.; Recanatini M.; Parrinello M.
Trypanothione reductase inhibitors as lead candidates to treat trypanosomatid diseases: recent advances and outlooks
2006 M.L. Bolognesi; A. Cavalli
Natural Cinchona Alkaloids as Organocatalytic Asymmetric Conjugate Addition of 1,3-Dicarbonyl Compounds to Maleimides
2006 P. Melchiorre; A. Carlone; A. Cavalli; P. Ricci; L. Sambri; G. Bartoli
Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects
2006 A. Antonello; A. Tarozzi; F. Morroni; A. Cavalli; M. Rosini; P. Hrelia; M.L. Bolognesi; C. Melchiorre.
Target-related applications of first principles quantum chemical methods in drug design
2006 Cavalli A.; Carloni P.; Recanatini M.
AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets
2006 Bottegoni G.; Rocchia W.; Recanatini M.; Cavalli A.
La metadinamica nello studio dell'energia libera di complessi recettoriali binari
2006 Masetti M.; Gervasio F. L.; Cavalli A.; Recanatini M.; Parrinello M.
Induced fit modeling nella beta-idrossiacil-ACP deidratasi (FabZ) di Plasmodium falciparum
2006 Colizzi F.; Perozzo R.; Scapozza L.; Cavalli A.; Recanatini M.
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme
2006 Gobbi S.; Cavalli A.; Rampa A.; Belluti F.; Piazzi L.; Paluszcak A.; Hartmann R.W.; Recanatini M.; Bisi A.
Conformational plasticity of kinase: molecular dynamics simulation of the conformational changes in the activation of Cdk5
2006 Cavalli A.; Berteotti A.; Branduardi D.; Gervasio F. L.; Recanatini M.; Parrinello M.
Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex
2006 De Vivo M.; Cavalli A.; Bottegoni G.; Carloni P.; Recanatini M.
Un modello di soluto polarizzabile per migliorare la procedura di stima delle cariche parziali
2006 Rocchia W.; Masetti M.; Cavalli A.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Computational approaches to the study of dual-site and peripheral site binding ache inhibitors | Recanatini M.; Cavalli A.; Bottegoni G. | 2005-01-01 | CHEMICO-BIOLOGICAL INTERACTIONS | - | 4.02 Riassunto (Abstract) | - |
Enantioselective nonsteroidal aromatase inhibitors identified through a multidisciplinary medicinal chemistry approach | Cavalli A.; Bisi A.; Bertucci C.; Rosini C.; Paluszcak A.; Gobbi S.; Giorgio E.; Rampa A.; Bellut...i F.; Piazzi L.; Valenti P.; Hartmann R.W.; Recanatini M. | 2005-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation. | Belluti F.; Rampa A.; Piazzi L.; Bisi A.; Gobbi S.; Bartolini M.; Andrisano V.; Cavalli A.; Recan...atini M.; Valenti P. | 2005-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Nonsteroidal Aromatase inhibitors: synthesis and evaluation of new flavone derivatives | S. Gobbi; A. Bisi; F. Belluti; L. Piazzi; A. Rampa; P. Valenti; A. Cavalli; A. Paluszcak; R.W. Ha...rtmann | 2005-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Heterocyclic inhibitors of AChE acylation and peripheral sites. | Bolognesi M. L.; Andrisano V.; Bartolini M.; Cavalli A.; Minarini A.; Recanatini M.; Rosini M.; T...umiatti V.; Melchiorre C. | 2005-01-01 | IL FARMACO | - | 1.01 Articolo in rivista | - |
QT prolongation through hERG K(+) channel blockade: Current knowledge and strategies for the early prediction during drug development | RECANATINI M.; POLUZZI E.; MASETTI M.; CAVALLI A.; DE PONTI F. | 2005-01-01 | MEDICINAL RESEARCH REVIEWS | - | 1.01 Articolo in rivista | - |
Organocatalytic Asymmetric Conjugate Addition of 1,3-Dicarbonyl Compounds to Maleimides | G. Bartoli; M. Bosco; A. Carlone; A. Cavalli; M. Locatelli; A. Mazzanti; P. Ricci; L. Sambri; P. ...Melchiorre | 2006-01-01 | ANGEWANDTE CHEMIE. INTERNATIONAL EDITION | - | 1.01 Articolo in rivista | - |
Three-dimensional model of the human aromatase enzyme and density functional parameterization of the iron-containing protoporphyrin IX for a molecular dynamics study of heme-cysteinato cytochromes. | Favia A. D.; Cavalli A.; Masetti M.; Carotti A.; Recanatini M. | 2006-01-01 | PROTEINS | - | 1.01 Articolo in rivista | - |
Essential dynamics and metadynamics studies of the conformational changes in the activation loop and PSSARLE of Cdk5 | Berteotti A.; Cavalli A.; Branduardi D.; Gervasio F. L.; Recanatini M.; Parrinello M. | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Trypanothione reductase inhibitors as lead candidates to treat trypanosomatid diseases: recent advances and outlooks | M.L. Bolognesi; A. Cavalli | 2006-01-01 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Natural Cinchona Alkaloids as Organocatalytic Asymmetric Conjugate Addition of 1,3-Dicarbonyl Compounds to Maleimides | P. Melchiorre; A. Carlone; A. Cavalli; P. Ricci; L. Sambri; G. Bartoli | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects |
A. Antonello; A. Tarozzi; F. Morroni; A. Cavalli; M. Rosini; P. Hrelia; M.L. Bolognesi; C.... Melchiorre. |
2006-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Target-related applications of first principles quantum chemical methods in drug design | Cavalli A.; Carloni P.; Recanatini M. | 2006-01-01 | CHEMICAL REVIEWS | - | 1.01 Articolo in rivista | - |
AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets | Bottegoni G.; Rocchia W.; Recanatini M.; Cavalli A. | 2006-01-01 | BIOINFORMATICS | - | 1.01 Articolo in rivista | - |
La metadinamica nello studio dell'energia libera di complessi recettoriali binari | Masetti M.; Gervasio F. L.; Cavalli A.; Recanatini M.; Parrinello M. | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Induced fit modeling nella beta-idrossiacil-ACP deidratasi (FabZ) di Plasmodium falciparum | Colizzi F.; Perozzo R.; Scapozza L.; Cavalli A.; Recanatini M. | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme | Gobbi S.; Cavalli A.; Rampa A.; Belluti F.; Piazzi L.; Paluszcak A.; Hartmann R.W.; Recanatini M....; Bisi A. | 2006-01-01 | JOURNAL OF MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Conformational plasticity of kinase: molecular dynamics simulation of the conformational changes in the activation of Cdk5 | Cavalli A.; Berteotti A.; Branduardi D.; Gervasio F. L.; Recanatini M.; Parrinello M. | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Role of phosphorylated Thr160 for the activation of the CDK2/Cyclin A complex | De Vivo M.; Cavalli A.; Bottegoni G.; Carloni P.; Recanatini M. | 2006-01-01 | PROTEINS | - | 1.01 Articolo in rivista | - |
Un modello di soluto polarizzabile per migliorare la procedura di stima delle cariche parziali | Rocchia W.; Masetti M.; Cavalli A. | 2006-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile